Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:18 pm Purchase | 2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT | A.G.P. / Alliance Global Partners, LLC | 73,888 9.800% | 73,888 (New Position) | Filing History |
| 2025-05-07 5:36 pm Purchase | 2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT | Sarborg Ltd | 123,596 16.400% | 123,596 (New Position) | Filing History |
| 2025-04-10 06:00 am Sale | 2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT | ASTRAZENECA PLC | 4,926 1.100% | -1,410 (-22.26%) | Filing History |
| 2025-02-20 4:32 pm Sale | 2025-02-19 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 0 0.000% | -10,233 (Position Closed) | Filing History |
| 2025-01-21 5:00 pm Purchase | 2025-01-13 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 10,233 9.979% | 8,900 (+667.50%) | Filing History |
| 2024-11-06 06:01 am Sale | 2024-09-03 | 13G | Conduit Pharmaceuticals Inc. CDT | St George Street Capital | 0 0.000% | -3,167 (Position Closed) | Filing History |
| 2024-10-18 4:15 pm Sale | 2024-10-11 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 1,333 2.000% | -4,061 (-75.28%) | Filing History |
| 2024-10-11 06:01 am Purchase | 2024-08-07 | 13G | Conduit Pharmaceuticals Inc. CDT | ASTRAZENECA PLC | 6,336 9.900% | 6,336 (New Position) | Filing History |
| 2024-10-07 7:36 pm Sale | 2024-10-04 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 5,395 8.300% | -4,272 (-44.19%) | Filing History |
| 2024-09-19 4:59 pm Sale | 2024-03-26 | 13D | Conduit Pharmaceuticals Inc. CDT | Corvus Capital Ltd. | 20,195 31.560% | -10,201 (-33.56%) | Filing History |
| 2024-08-13 4:29 pm Purchase | 2024-08-06 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 9,667 14.800% | 5,320 (+122.38%) | Filing History |
| 2024-02-12 12:51 pm Purchase | 2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT | Polar Asset Management Partners Inc. | 633 1.300% | 633 (New Position) | Filing History |
| 2024-02-08 1:15 pm Unchanged | 2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT | Saba Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-02 4:28 pm Purchase | 2023-12-31 | 13G | Conduit Pharmaceuticals Inc. CDT | Hudson Bay Capital Management LP | 49 0.100% | 49 (New Position) | Filing History |
| 2023-10-02 4:30 pm Purchase | 2023-09-22 | 13G | Conduit Pharmaceuticals Inc. CDT | Nirland Limited | 4,347 8.800% | 4,347 (New Position) | Filing History |
| 2023-09-29 4:30 pm Purchase | 2023-09-22 | 13D | Conduit Pharmaceuticals Inc. CDT | Corvus Capital Ltd. | 30,396 62.960% | 30,396 (New Position) | Filing History |
| 2023-09-29 4:30 pm Purchase | 2023-09-22 | 13D | Conduit Pharmaceuticals Inc. CDT | Murphy Canyon Acquisition Sponsor LLC | 3,150 6.500% | 3,150 (New Position) | Filing History |
| 2023-09-29 4:30 pm Purchase | 2023-09-22 | 13G | Conduit Pharmaceuticals Inc. CDT | St George Street Capital | 3,167 6.600% | 3,167 (New Position) | Filing History |
| 2023-02-16 5:28 pm Purchase | 2022-02-13 | 13D | Murphy Canyon Acquisition Corp. MURF | Shaolin Capital Management LLC | 609,750 20.730% | 609,750 (New Position) | Filing History |
| 2023-02-14 12:08 pm Purchase | 2022-12-31 | 13G | Murphy Canyon Acquisition Corp. MURF | MMCAP International Inc. SPC | 350,000 2.500% | 350,000 (New Position) | Filing History |